M&A Deal Summary |
|
---|---|
Date | 2020-12-21 |
Target | RealPage |
Sector | Software |
Buyer(s) |
Thoma Bravo
Alberta Investment Management |
Deal Type | Going Private |
Deal Value | 10.2B USD |
Advisor(s) | BofA Securities (Financial) Wachtell, Lipton, Rosen & Katz (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1980 |
PE ASSETS | 127.0B USD |
Size | Mega |
Type | Sector Agnostic |
Thoma Bravo is a private equity firm that primarily invests in or acquires US-based middle-market businesses. While Thoma Bravo will consider a variety of transaction situations, including take-privates, buyouts, carve-outs, recapitalizations, and growth equity financings, the Firm has a special interest in tech consolidation opportunities. Target companies generally have a history of profitability with EBITDA of at least $20 million. The Firm's equity commitment size range is $100 to $750 million. Sectors of interest include enterprise and infrastructure software, education, distribution, financial services and consumer goods/services. The Firm will not invest in new inventions or technologies, developmental products or services, start-ups, biotech, motion pictures, distressed businesses, oil/gas, or real estate. Thoma Bravo was formerly known as Thoma Cressey Bravo and before that Golder Thoma & Co. The Firm was originally formed in 1980 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 98 of 140 |
Sector (Software) | 44 of 59 |
Type (Going Private) | 22 of 39 |
State (Texas) | 13 of 18 |
Country (United States) | 90 of 120 |
Year (2020) | 11 of 11 |
Size (of disclosed) | 3 of 47 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-12-21 |
Zipari
Brooklyn, New York, United States Zipari is a healthcare technology company that develops products for health insurance carriers to engage with consumers in new and innovative ways. Zipari was founded in 2014 and is based in Brooklyn, New York. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-01-25 |
Segall Bryant & Hamill
Chicago, Illinois, United States Segall Bryant & Hamill (SBH) is an independent firm headquartered in Chicago, with offices in Denver, St. Louis, Philadelphia, and Naples, Florida. The firm was established in 1994. SBH offers a range of investment strategies and customized solutions for institutional, advisor and wealth management clients, including domestic, international and global equity, fixed income and alternatives. The firm has approximately $20 billion of assets under management or advisement. |
Sell | - |
Category | Pension |
---|---|
Founded | 2008 |
PE ASSETS | 4.5B CAD |
Size | Mega |
Type | Sector Agnostic |
Alberta Investment Management Corporation (AIMCo) is a Canadian diversified institutional investment manager serving pension, endowment and government funds in the province of Alberta. In addition to investing in public equities, fixed income, and debt, AIMCo looks to invest in private equity, real estate, timberlands, and infrastructure. AIMCo's private equity group invests in funds and directly in companies throughout North America and Western Europe. Areas of interest include consumer, industrials, business services, financial services, technology, and healthcare. AIMCo is based in Edmonton, with additional offices in Toronto and London.
DEAL STATS | # |
---|---|
Overall | 22 of 30 |
Sector (Software) | 3 of 3 |
Type (Going Private) | 1 of 3 |
State (Texas) | 2 of 3 |
Country (United States) | 10 of 15 |
Year (2020) | 3 of 3 |
Size (of disclosed) | 2 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-11-19 |
nThrive - Technology Division
Alpharetta, Georgia, United States nThrive's Technology Division is a healthcare revenue cycle management ("RCM") software-as-a-service ("SaaS") platform. nThrive's Technology Division is based in Alpharetta, Georgia. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-02-01 |
Recipharm
Stockholm, Sweden Recipharm is a global Pharma CDMO providing a full-service offering to leading Pharmaceutical companies and Biotechs globally. Recipharm was founded in 1995 and is based in Stockholm, Sweden. |
Buy | - |